Summary
A study of percutaneous absorption of the anti-herpetic agent 5-iodo-2′ deoxycytidine (IDe) was performedin vitro on the rat and on man andin vivo on the rat, using samples of normal skin and skin stripped of its stratum corneum.
With normal skin, absorption was 1.84 cm.h1 10−4 for the rat and 0.33 cm.h1 10−4 for human skin; when the stratum corneum wasabsent, absorption wasapproximatively 15 times higher. The results are discussed in termsof efficacy and toxicity of the drug.
Similar content being viewed by others
References
Wester R.C., Noonan P.K. (1980): Relevance of animals models for percutaneous absorption. Int. J. Pharm.,7. 99–110.
Laskin O.L., Griffin D.E., Lietman P.S. (1981): Selective uptake of125I. IDC in cells infected with Herpes H.S.V. I. J. Infect. Dis.,144. 78.
Wepierre J. (1979): Facteurs physiques et physiologiques intervenant dans I’ absorption percutanée des médicaments. Actual. Pharmacol., 31c Série, 169–202.
Wepierre J., Marty J.P. (1981): Absorption des médicaments par voie percutanée: bases theoriques, Sci. Tech. Pharm.10. 467–483.
Mc Greesh A.H. (1965): Percutaneous toxicity. Toxicol. Appl. Pharmacol., Suppl.2. 20–26.
Marzulli F.N., Brown D.W.C., Maibach H.I. (1969): Techniques for studying skin penetration. Toxicol. Appl. Pharmacol., Suppl.3. 76–83.
Tregear R.T. (1966): Physical function of skin. Academic Press, New York.
Schwartz D. (1969): Méthodes statistiques à I’usage des médecins et des biologistes. 3e éd., Flammarion, Paris.
Tanaka H., Watanabe M., Asahi K., Izuka T. (1970): Toxicité subaiguë de la 5-iodo-2′ deoxycytidine et de la 4-iodo-2′ deoxyuridine. Oyo Yakuri,4. 511–520.
Calabresi P., Creasey W.A., Prusoff W.H., Welch A.D. (1963): Clinical and pharmacological studies with 5-isodo-2′ deoxycytidine. Cancer Res.,23. 583–592
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wepierre, J., Marty, J.P., Chanal, J.L. et al. Percutaneous Absorption of 5-iodo-2′deoxycytidine in the hairless rat and in man. European Journal of Drug Metabolism and Pharmacokinetics 9, 79–83 (1984). https://doi.org/10.1007/BF03189608
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03189608